EFFECTS OF SEX AND AGE ON THE GROWTH-HORMONE RESPONSE TO GALANIN IN HEALTHY-HUMAN SUBJECTS

被引:52
|
作者
GIUSTINA, A
LICINI, M
BUSSI, AR
GIRELLI, A
PIZZOCOLO, G
SCHETTINO, M
NEGROVILAR, A
机构
[1] UNIV BRASILIA, CATTEDRA CLIN MED & CHIM, BR-70910 BRASILIA, DF, BRAZIL
[2] NIEHS, MOLEC & INTEGRAT NEUROSCI LAB, RES TRIANGLE PK, NC 27709 USA
关键词
D O I
10.1210/jc.76.5.1369
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The aim of our study was to analyze the effects of sex an age on the GH response to galanin infusion in healthy subjects. We have studied 12 young (age, <40 yr) nonobese healthy volunteers [6 females: age, 31.0 +/- 2.5 yr; body mass index (BMI), 21.6 +/- 0.9 kg/m2; 6 males: age, 29.2 +/- 1.4 yr; BMI, 23.3 +/- 0.4 kg/m2] and 11 old (age, >65 yr) healthy subjects (5 females: age, 83.8 +/- 3.8 yr; BMI, 23.4 +/- 1.4 k g/M2; 6 males: age, 79.7 +/- 4.6 yr; BMI, 23.3 +/- 0.2 kg/m2). All subjects received an infusion of synthetic porcine galanin (500 mug, iv) in 100 mL saline from 0-45 min. Blood samples for GH measurement were drawn at -15, 0, 15, 30, 45, 60, 90, and 120 min. The GH peaks after galanin treatment in young females (11.9 +/- 2.9 mug/L) were significantly (P < 0.05) higher than those in the young males (5.1 +/- 1.8 mug/L). Old males showed significantly higher peak GH levels after galanin treatment (8.6 +/- 3.1 mug/L) than old females (2.4 +/- 0.6 mug/L). The GH peaks and areas under the curve after galanin treatment were significantly (P < 0.05) higher in young than in old females. On the contrary, no significant differences were observed after galanin treatment in young and old males. The magnitude of galanin-induced GH secretion significantly correlated with estradiol levels in young women. Our data seem to suggest that circulating estrogen levels play a crucial permissive role in galanin-induced GH secretion in humans.
引用
收藏
页码:1369 / 1372
页数:4
相关论文
共 50 条
  • [41] THE PSYCHOPHARMACOLOGICAL AND ELECTROPHYSIOLOGICAL EFFECTS OF SINGLE DOSES OF CAFFEINE IN HEALTHY-HUMAN SUBJECTS
    BRUCE, M
    SCOTT, N
    LADER, M
    MARKS, V
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1986, 22 (01) : 81 - 87
  • [42] THE 24-H PATTERN OF HUMAN-PROLACTIN AND GROWTH-HORMONE IN HEALTHY ELDERLY SUBJECTS
    MURRI, L
    BARRECA, T
    CERONE, G
    MASSETANI, R
    GALLAMINI, A
    BALDASSARRE, M
    CHRONOBIOLOGIA, 1980, 7 (01) : 87 - 92
  • [43] DOSE-RESPONSE RELATIONSHIP FOR ORAL IDAZOXAN EFFECTS IN HEALTHY-HUMAN SUBJECTS - COMPARISON WITH ORAL YOHIMBINE
    KRYSTAL, JH
    MCDOUGLE, CJ
    WOODS, SW
    PRICE, LH
    HENINGER, GR
    CHARNEY, DS
    PSYCHOPHARMACOLOGY, 1992, 108 (03) : 313 - 319
  • [44] THE FATE OF INGESTED LACTITOL IN HEALTHY-HUMAN SUBJECTS
    GRIMBLE, GK
    PATIL, DH
    SILK, DBA
    GASTROENTEROLOGY, 1986, 90 (05) : 1440 - 1440
  • [45] EFFECTS OF HUMAN GROWTH-HORMONE ON CATABOLISM
    GOTTARDIS, M
    HACKL, JM
    ANAESTHESIST, 1988, 37 (10): : 655 - 655
  • [46] ACUTE EFFECTS OF CORTISONE-ACETATE ON GROWTH-HORMONE RESPONSE TO GROWTH HORMONE-RELEASING HORMONE IN NORMAL ADULT SUBJECTS
    GIUSTINA, A
    DOGA, M
    BODINI, C
    GIRELLI, A
    LEGATI, F
    BOSSONI, S
    ROMANELLI, G
    ACTA ENDOCRINOLOGICA, 1990, 122 (02): : 206 - 210
  • [47] EFFECT OF HUMAN GALANIN ON GROWTH-HORMONE PROLACTIN AND ANTIDIURETIC-HORMONE SECRETION IN NORMAL MEN
    MURAKAMI, Y
    OHSHIMA, K
    MOCHIZUKI, T
    YANAIHARA, N
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1993, 77 (05) : 1436 - 1438
  • [48] EFFECTS OF NALOXONE ON PROLACTIN, GROWTH-HORMONE AND CORTISOL RESPONSE TO INSULIN HYPOGLYCEMIA IN OBESE SUBJECTS
    PAPALIA, D
    LUNETTA, M
    DIMAURO, M
    JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, 1989, 12 (11) : 777 - 782
  • [49] THE EFFECT OF A CCK ANTAGONIST, PROGLUMIDE, ON THE GASTROCOLIC MOTOR RESPONSE IN HEALTHY-HUMAN SUBJECTS
    SHANNON, S
    REDDY, N
    WATERFALL, W
    CAMPBELL, D
    GOODACRE, R
    COLLINS, S
    GASTROENTEROLOGY, 1986, 91 (04) : 1067 - 1067
  • [50] EFFECTS OF LOVASTATIN AND DIETARY-CHOLESTEROL ON STEROL HOMEOSTASIS IN HEALTHY-HUMAN SUBJECTS
    DUANE, WC
    JOURNAL OF CLINICAL INVESTIGATION, 1993, 92 (02) : 911 - 918